Pfizer booster shot: The ‘unexpected’ side effect after third dose - Pfizer finding

Belgique Nouvelles Nouvelles

Pfizer booster shot: The ‘unexpected’ side effect after third dose - Pfizer finding
Belgique Dernières Nouvelles,Belgique Actualités
  • 📰 Daily Express
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 68%

THE UK has begun launching its booster shot programme in a bid to stave off a third wave of infections ahead of winter. New data released by the FDA has highlighted which side effects are to be expected after receiving a booster dose of the Pfizer vaccine.

The side effect appeared within four days of the shot, and all but one case of the condition were considered mild.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

Daily Express /  🏆 26. in UK

Belgique Dernières Nouvelles, Belgique Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

FDA advisers to debate safety of recommending Pfizer booster shotsFDA advisers to debate safety of recommending Pfizer booster shotsPanel’s decision will be important milestone in White House plan to provide Covid boosters eight months after full vaccination
Lire la suite »

Pfizer recall anti-smoking drug Chantix for high levels nitrosaminePfizer recall anti-smoking drug Chantix for high levels nitrosaminePfizer has voluntarily recalled its drug Chantix - which is used to help people stop smoking - for containing high levels of cancer-causing agents called nitrosamines.
Lire la suite »

FDA advisers to debate safety of recommending Pfizer booster shotsFDA advisers to debate safety of recommending Pfizer booster shotsPanel’s decision will be important milestone in White House plan to provide Covid boosters eight months after full vaccination
Lire la suite »

People with chronic conditions among most at risk from Covid even after jabsPeople with chronic conditions among most at risk from Covid even after jabsResearch finds those with Down’s syndrome, Parkinson’s and other conditions may benefit from booster dose
Lire la suite »

New drug could slow tumour regrowth in inoperable bowel cancerNew drug could slow tumour regrowth in inoperable bowel cancerAdavosertib found to delay tumour growth in some patients in clinical trial, with few side effects
Lire la suite »

Pfizer recall anti-smoking drug Chantix for high levels nitrosaminePfizer recall anti-smoking drug Chantix for high levels nitrosaminePfizer has voluntarily recalled its drug Chantix - which is used to help people stop smoking - for containing high levels of cancer-causing agents called nitrosamines.
Lire la suite »



Render Time: 2025-04-18 07:53:19